OrthoPediatrics Corp. (KIDS) Financial Ratios
12 years of historical data (2014–2025) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
1.19
↓-50% vs avg
5yr avg: 2.40
30Y Low1.2·High5.4
ROE
↓
-11.3%
↑-67% vs avg
5yr avg: -6.8%
30Y Low-76%·High0%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
KIDS Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
OrthoPediatrics Corp. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $444M | $417M | $535M | $737M | $832M | $1.2B | $745M | $687M | $438M | $92M | — |
| Enterprise Value | $525M | $497M | $572M | $716M | $824M | $1.2B | $741M | $643M | $399M | $75M | — |
| P/E Ratio → | -10.40 | — | — | — | 673.39 | — | — | — | — | — | — |
| P/S Ratio | 1.88 | 1.76 | 2.61 | 4.96 | 6.81 | 11.76 | 10.48 | 9.47 | 7.62 | 2.03 | — |
| P/B Ratio | 1.19 | 1.20 | 1.51 | 1.96 | 2.20 | 5.12 | 3.17 | 4.83 | 5.36 | 1.95 | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
KIDS EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.10 | 2.79 | 4.82 | 6.74 | 11.96 | 10.43 | 8.86 | 6.93 | 1.65 | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
KIDS Profitability
Margins and return-on-capital ratios measuring operating efficiency
OrthoPediatrics Corp. earns an operating margin of -12.3%. Operating margins have expanded from -18.0% to -12.3% over the past 3 years, signaling improving operational efficiency. A negative ROE of -11.3% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.1% | 73.1% | 72.6% | 74.8% | 74.1% | 74.9% | 77.4% | 75.3% | 74.2% | 75.5% | 70.7% |
| Operating Margin | -12.3% | -12.3% | -14.4% | -18.0% | -20.8% | -18.4% | -37.6% | -12.5% | -16.6% | -14.2% | -16.4% |
| Net Profit Margin | -16.8% | -16.8% | -18.5% | -14.1% | 1.0% | -16.6% | -46.3% | -18.9% | -20.9% | -19.6% | -17.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -11.3% | -11.3% | -10.3% | -5.6% | 0.4% | -7.1% | -17.5% | -12.3% | -18.6% | -33.4% | -75.9% |
| ROA | -8.1% | -8.1% | -8.3% | -4.8% | 0.3% | -5.1% | -12.7% | -9.0% | -12.4% | -15.8% | -21.4% |
| ROIC | -5.3% | -5.3% | -5.9% | -5.5% | -6.2% | -5.7% | -12.2% | -9.7% | -19.7% | -18.6% | -21.6% |
| ROCE | -6.4% | -6.4% | -7.1% | -6.7% | -7.5% | -6.3% | -11.4% | -6.4% | -10.9% | -13.4% | -25.6% |
KIDS Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $80M ($100M total debt minus $20M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.29 | 0.29 | 0.23 | 0.03 | 0.00 | 0.13 | 0.11 | 0.18 | 0.26 | 0.54 | 2.93 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.23 | 0.10 | -0.06 | -0.02 | 0.09 | -0.02 | -0.31 | -0.48 | -0.36 | 2.66 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -4.86 | -4.86 | -11.26 | — | -8.99 | -7.95 | -8.87 | -2.59 | -4.33 | -2.59 | -3.45 |
KIDS Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
OrthoPediatrics Corp.'s current ratio of 5.55x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.65x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 5.44x to 5.55x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.55 | 5.55 | 6.98 | 5.44 | 7.34 | 4.50 | 4.52 | 9.37 | 10.54 | 7.35 | 2.87 |
| Quick Ratio | 2.65 | 2.65 | 3.54 | 2.90 | 4.81 | 2.56 | 3.01 | 6.59 | 7.75 | 5.18 | 0.82 |
| Cash Ratio | 1.32 | 1.32 | 2.03 | 1.93 | 3.83 | 1.85 | 2.43 | 5.18 | 6.58 | 4.50 | 0.22 |
| Asset Turnover | — | 0.46 | 0.43 | 0.34 | 0.29 | 0.32 | 0.22 | 0.37 | 0.51 | 0.55 | 1.22 |
| Inventory Turnover | 0.48 | 0.48 | 0.48 | 0.35 | 0.40 | 0.43 | 0.30 | 0.47 | 0.58 | 0.54 | 0.73 |
| Days Sales Outstanding | — | 83.14 | 75.52 | 84.95 | 74.02 | 66.79 | 90.12 | 83.35 | 60.25 | 44.83 | 40.10 |
KIDS Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
OrthoPediatrics Corp. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | 6.5% | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 0.1% | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.1% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 7.5% | — |
| Shares Outstanding | — | $23M | $23M | $23M | $21M | $19M | $18M | $15M | $13M | $5M | $8M |
Peer Comparison
Compare KIDS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 KIDSYou | $444M | -10.4 | — | — | 73.1% | -12.3% | -11.3% | -5.3% | — |
 ATEC | $1B | -8.1 | 3752.1 | 422.6 | 69.6% | -10.7% | -630.7% | -12.6% | 1425.2 |
 XTNT | $80M | -4.8 | — | — | 58.2% | -10.3% | -34.9% | -12.8% | — |
 GMED | $12B | 21.7 | 18.5 | 19.5 | 67.4% | 16.3% | 12.3% | 8.9% | 0.2 |
 ZBH | $16B | 23.5 | 9.5 | 11.1 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 |
 SYK | $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 MDXG | $548M | 11.5 | 5.1 | 7.5 | 82.6% | 15.3% | 21.6% | 42.3% | 0.3 |
 OFIX | $488M | -5.3 | — | — | 67.1% | -8.3% | -19.3% | -8.6% | — |
 NVCR | $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 MDT | $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 JNJ | $536B | 38.4 | 18.6 | 27.0 | 69.1% | 24.9% | 20.1% | 20.7% | 1.2 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 12 years · Updated daily
See KIDS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KIDS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare KIDS vs ATEC
Side-by-side business, growth, and profitability comparison vs Alphatec Holdings, Inc..
Start ComparisonKIDS — Frequently Asked Questions
Quick answers to the most common questions about buying KIDS stock.
What is OrthoPediatrics Corp.'s P/E ratio?
OrthoPediatrics Corp.'s current P/E ratio is -10.4x. This places it at the 50th percentile of its historical range.
What is OrthoPediatrics Corp.'s ROE?
OrthoPediatrics Corp.'s return on equity (ROE) is -11.3%. The historical average is -24.9%.
Is KIDS stock overvalued?
Based on historical data, OrthoPediatrics Corp. is trading at a P/E of -10.4x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are OrthoPediatrics Corp.'s profit margins?
OrthoPediatrics Corp. has 73.1% gross margin and -12.3% operating margin.